Changchun High-Tech Industry (Group) Co., Ltd.

SZSE:000661 Stock Report

Market Cap: CN¥41.3b

Changchun High-Tech Industry (Group) Valuation

Is 000661 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 000661 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CN¥66.19
Fair Value
55.0% overvalued intrinsic discount
3
Number of Analysts

Below Fair Value: 000661 (CN¥102.6) is trading above our estimate of fair value (CN¥66.19)

Significantly Below Fair Value: 000661 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 000661?

Key metric: As 000661 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 000661. This is calculated by dividing 000661's market cap by their current earnings.
What is 000661's PE Ratio?
PE Ratio43.1x
EarningsCN¥959.05m
Market CapCN¥41.34b

Price to Earnings Ratio vs Peers

How does 000661's PE Ratio compare to its peers?

The above table shows the PE ratio for 000661 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.5x
600085 Beijing Tongrentang
35.6x22.19%CN¥48.2b
600079 Humanwell Healthcare (Group)Ltd
22.9x21.32%CN¥32.7b
002422 Sichuan Kelun Pharmaceutical
32.4x30.52%CN¥54.0b
000513 Livzon Pharmaceutical Group
15.1x10.52%CN¥29.9b
000661 Changchun High-Tech Industry (Group)
43.1x27.45%CN¥41.3b

Price-To-Earnings vs Peers: 000661 is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the peer average (26.5x).

Price to Earnings Ratio vs Industry

How does 000661's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
000661 43.1xIndustry Avg. 36.6xNo. of Companies27PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 000661 is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the CN Pharmaceuticals industry average (36.6x).

Price to Earnings Ratio vs Fair Ratio

What is 000661's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

000661 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio43.1x
Fair PE Ratio38.7x

Price-To-Earnings vs Fair Ratio: 000661 is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the estimated Fair Price-To-Earnings Ratio (38.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 000661 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥102.60
CN¥136.00
+32.56%
15.20%CN¥156.00CN¥107.53n/a3
Nov ’26CN¥112.26
CN¥136.00
+21.15%
15.20%CN¥156.00CN¥107.53n/a3
Oct ’26CN¥130.00
CN¥136.00
+4.62%
15.20%CN¥156.00CN¥107.53n/a3
Sep ’26CN¥113.37
CN¥107.17
-5.47%
0.34%CN¥107.53CN¥106.80n/a2
Aug ’26CN¥105.69
CN¥107.17
+1.40%
0.34%CN¥107.53CN¥106.80n/a2
Jul ’26CN¥100.00
CN¥107.17
+7.16%
0.34%CN¥107.53CN¥106.80n/a2
Jun ’26CN¥104.56
CN¥107.17
+2.49%
0.34%CN¥107.53CN¥106.80n/a2
Nov ’25CN¥104.04
CN¥162.29
+55.98%
17.01%CN¥189.89CN¥134.68CN¥112.262
Oct ’25CN¥109.89
CN¥166.35
+51.37%
14.15%CN¥189.89CN¥142.80CN¥130.002
Sep ’25CN¥82.32
CN¥166.35
+102.07%
14.15%CN¥189.89CN¥142.80CN¥113.372
Aug ’25CN¥92.46
CN¥195.35
+111.28%
2.79%CN¥200.80CN¥189.89CN¥105.692
Jul ’25CN¥93.29
CN¥195.35
+109.40%
2.79%CN¥200.80CN¥189.89CN¥100.002
Jun ’25CN¥104.81
CN¥195.35
+86.38%
2.79%CN¥200.80CN¥189.89CN¥104.562
May ’25CN¥113.06
CN¥195.35
+72.78%
2.79%CN¥200.80CN¥189.89CN¥87.902
Apr ’25CN¥123.76
CN¥203.00
+64.03%
2.23%CN¥207.52CN¥198.48CN¥102.062
Mar ’25CN¥129.10
CN¥211.29
+63.66%
0.31%CN¥211.95CN¥210.63CN¥94.982
Feb ’25CN¥114.64
CN¥211.29
+84.31%
0.31%CN¥211.95CN¥210.63CN¥92.972
Jan ’25CN¥145.80
CN¥211.29
+44.92%
0.31%CN¥211.95CN¥210.63CN¥99.442
Dec ’24CN¥158.89
CN¥211.29
+32.98%
0.31%CN¥211.95CN¥210.63CN¥107.222
Nov ’24CN¥156.32
CN¥211.29
+35.17%
0.31%CN¥211.95CN¥210.63CN¥104.042
CN¥136
Fair Value
24.6% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 23:30
End of Day Share Price 2025/11/18 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Changchun High-Tech Industry (Group) Co., Ltd. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Yanyin ZhuChina International Capital Corporation Limited
Chao LiCitic Securities Co., Ltd.